Your browser doesn't support javascript.
loading
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
Yokota, Tomoya; Kato, Ken; Hamamoto, Yasuo; Tsubosa, Yasuhiro; Ogawa, Hirofumi; Ito, Yoshinori; Hara, Hiroki; Ura, Takashi; Kojima, Takashi; Chin, Keisho; Hironaka, Shuichi; Kii, Takayuki; Kojima, Yasushi; Akutsu, Yasunori; Matsushita, Hisayuki; Kawakami, Kentaro; Mori, Keita; Makiuchi, Takashi; Nagumo, Rie; Kitagawa, Yuko.
Afiliação
  • Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan. t.yokota@scchr.jp.
  • Kato K; Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Hamamoto Y; Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo, Japan.
  • Tsubosa Y; Division of Esophageal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ogawa H; Division of Radiation Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ito Y; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hara H; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Kojima T; Department of Gastroenterology, National Cancer Center Hospital East, Chiba, Japan.
  • Chin K; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hironaka S; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Kii T; Cancer Chemotherapy Center, Osaka Medical College Hospital, Osaka, Japan.
  • Kojima Y; Department of Gastroenterology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Akutsu Y; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Matsushita H; Department of Surgery, Tochigi Cancer Center, Tochigi, Japan.
  • Kawakami K; Department of Medical Oncology, Tochigi Cancer Center, Tochigi, Japan.
  • Mori K; Clinical Trial Coordination Office, Shizuoka Cancer Center, Shizuoka, Japan.
  • Makiuchi T; Clinical Data Management, Clinical Research Data Center, National Cancer Center Hospital, Tokyo, Japan.
  • Nagumo R; Clinical Data Management, Clinical Research Data Center, National Cancer Center Hospital, Tokyo, Japan.
  • Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
Ann Surg Oncol ; 27(2): 460-467, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31376034
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Esofagectomia / Quimiorradioterapia / Quimioterapia de Indução / Carcinoma de Células Escamosas do Esôfago / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Esofagectomia / Quimiorradioterapia / Quimioterapia de Indução / Carcinoma de Células Escamosas do Esôfago / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article